Literature DB >> 8383968

Characterization of the bovine brain cytosolic phosphatidylinositol 3-kinase complex.

F Ruiz-Larrea1, P Vicendo, P Yaish, P End, G Panayotou, M J Fry, S J Morgan, A Thompson, P J Parker, M D Waterfield.   

Abstract

Receptor-linked phosphatidylinositol (PtdIns) 3-kinase may generate a second-messenger signal. Here a large-scale purification of the bovine brain enzyme, based on methods developed by Morgan, Smith and Parker [(1990) Eur. J. Biochem. 191, 761-767] and Fry, Panayotou, Dhand, Ruiz-Larrea, Gout, Nguyen, Courtneidge and Waterfield [(1992) Biochem. J. 288, 383-393] is described. The purified enzyme is shown to be a heterodimer of 85 kDa and 110 kDa protein subunits (p85 and p110). Labelling with 5'-p-fluorosulphonylbenzoyladenosine shows that p110 contains an ATP-binding site and confers catalytic activity to the complex. The purified complex is known to be highly phosphorylated on both p85 alpha and p110 subunits, and dephosphorylation generates a deactivated complex, indicating that phosphorylation is an important covalent modification of the complex and may modulate PtdIns 3-kinase activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383968      PMCID: PMC1132318          DOI: 10.1042/bj2900609

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns.

Authors:  M J Fry; G Panayotou; R Dhand; F Ruiz-Larrea; I Gout; O Nguyen; S A Courtneidge; M D Waterfield
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit.

Authors:  I D Hiles; M Otsu; S Volinia; M J Fry; I Gout; R Dhand; G Panayotou; F Ruiz-Larrea; A Thompson; N F Totty
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

3.  Dot-blot hybridization: quantitative analysis with direct beta counting.

Authors:  M A Sognier; R E Neft; A L Roe; R L Eberle; J A Belli
Journal:  Biotechniques       Date:  1991-10       Impact factor: 1.993

4.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.

Authors:  M Otsu; I Hiles; I Gout; M J Fry; F Ruiz-Larrea; G Panayotou; A Thompson; R Dhand; J Hsuan; N Totty
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

5.  PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254.

Authors:  H K Kim; J W Kim; A Zilberstein; B Margolis; J G Kim; J Schlessinger; S G Rhee
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

6.  Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system.

Authors:  I Gout; R Dhand; G Panayotou; M J Fry; I Hiles; M Otsu; M D Waterfield
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

7.  "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides.

Authors:  R S Huang; A Sorisky; W R Church; E R Simons; S E Rittenhouse
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

8.  Identification, characterization and purification to near-homogeneity of a novel 67 kDa phosphotyrosyl protein phosphatase associated with pig lung annexin extract.

Authors:  P Vicendo; J Fauvel; J M Ragab-Thomas; H Chap
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

9.  Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils.

Authors:  L R Stephens; K T Hughes; R F Irvine
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

10.  CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T-cell line.

Authors:  D J Park; H W Rho; S G Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

View more
  7 in total

1.  Distinctive regulation of v-Src-associated phosphatidylinositol 3-kinase during PC12 cell differentiation.

Authors:  B Haefner; M C Frame
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

2.  The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes.

Authors:  S Roche; R Dhand; M D Waterfield; S A Courtneidge
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

Review 3.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

Authors:  P R Shepherd; D J Withers; K Siddle
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

4.  Autophosphorylation of serine 608 in the p85 regulatory subunit of wild type or cancer-associated mutants of phosphoinositide 3-kinase does not affect its lipid kinase activity.

Authors:  Meredith J Layton; Mirette Saad; Nicole L Church; Richard B Pearson; Christina A Mitchell; Wayne A Phillips
Journal:  BMC Biochem       Date:  2012-12-27       Impact factor: 4.059

5.  PI 3-kinase: structural and functional analysis of intersubunit interactions.

Authors:  R Dhand; K Hara; I Hiles; B Bax; I Gout; G Panayotou; M J Fry; K Yonezawa; M Kasuga; M D Waterfield
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

6.  PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity.

Authors:  R Dhand; I Hiles; G Panayotou; S Roche; M J Fry; I Gout; N F Totty; O Truong; P Vicendo; K Yonezawa
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

7.  Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells.

Authors:  L Stephens; A Eguinoa; S Corey; T Jackson; P T Hawkins
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.